مجلة كلية الطب, 2021 Background: A significant proportion of patients with ischemic heart disease have been associated with peripheral arterial disease, yet it is still underestimated by our health system as many of patients are asymptomatic and this condition remains under ...
Osama A. Altaei, Abbass N. Al-Sharifi
doaj +1 more source
PLoS ONE, 2019 BackgroundThe measurement of the ankle-brachial pressure index is a straightforward method for the detection of peripheral disease in the lower limbs. Only a few old studies with small numbers of patients have been conducted comparing the gold standard ...
Nadjib Schahab +7 more
doaj +1 more source
Ischemia-modified albumin in type 2 diabetic patients with and without peripheral arterial disease
Clinics, 2011 OBJECTIVE: To determine whether there is an association between serum ischemia-modified albumin and the risk factor profile in type 2 diabetic patients with peripheral arterial disease and to identify the risk markers for peripheral arterial disease ...
Shao-Gang Ma +3 more
doaj +1 more source
Antithrombotic therapy in peripheral arterial disease
Frontiers in Cardiovascular Medicine, 2022 BackgroundPatients with peripheral arterial disease (PAD) are at increased risk for major adverse cardiovascular events (MACE) such as cardiovascular death, myocardial infarction, and stroke as well as major adverse limb events (MALE) such as amputation ...
Christine Espinola-Klein +5 more
doaj +1 more source
Living a burdensome and demanding life: a qualitative systematic review of the patients experiences of peripheral arterial disease [PDF]
, 2018 BackgroundPeripheral arterial disease (PAD) has a significant negative impact on the quality of life of individuals. Understanding the experiences of people living with PAD will be useful in developing comprehensive patient-centred secondary prevention ...
Abaraogu, Ukachukwu Okoroafor +3 more
core +2 more sources
Preventive Therapies in Peripheral Arterial Disease
Biomedicines, 2023 Atherosclerosis, while initially deemed a bland proliferative process, is now recognized as a multifactorial-lipoprotein-mediated inflammation-driven pathway.
Aangi J. Shah +2 more
doaj +1 more source
Acute lower limb ischemia due to thrombo-embolic arterial occlusions in two previously healthy men with markedly elevated Lp(a) [PDF]
, 2006 Lipoprotein (a) (Lp(a)) is a well-documented risk factor for atherosclerotic cardiovascular disease. Its role in acute thrombo-embolic occlusions of peripheral arteries is not known.
Federico Tatò +6 more
core +3 more sources
Barriers and enablers to walking in individuals with intermittent claudication: a systematic review to conceptualize a relevant and patient-centered program [PDF]
, 2018 Background: Walking limitation in patients with peripheral arterial disease (PAD) and intermittent claudication (IC) contributes to poorer disease outcomes.
Abaraogu, Ukachukwu +7 more
core +5 more sources
Silence of the limbs: pharmacological symptomatic treatment of intermittent claudication [PDF]
, 2010 Several oral "vasoactive" drugs claim to increase walking capacity in patients with intermittent claudication (IC). Naftidrofuryl, cilostazol, buflomedil, and pentoxifylline are the most studied molecules.
De Backer, Gui +4 more
core +1 more source
Prevalence of peripheral arterial disease and related risk factors in Turkish elders
BMC Family Practice, 2011 Background It is known that prevalence of peripheral arterial disease being a widespread atherosclerotic vascular disease increases by age. On the other hand, no comprehensive study showing the prevalence of peripheral arterial disease in Turkish elders ...
Yesilkayali Teoman +3 more
doaj +1 more source